Screener
Beta Bionics BBNX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Beta Bionics’s reported figures.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
FAQ
- What is Beta Bionics's free cash flow?
- Beta Bionics (BBNX) reported free cash flow of -$15.66M in Q2 2026.
- How has Beta Bionics's free cash flow changed year-over-year?
- Beta Bionics's free cash flow decreased by 1.9% year-over-year, from -$15.37M to -$15.66M.
- What is the long-term trend for Beta Bionics's free cash flow?
- Over 2 years (2023 to 2025), Beta Bionics's free cash flow has grown at a 30.8% compound annual growth rate (CAGR), from -$32.85M to -$56.22M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Beta Bionics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude